Skip to main content
. 2024 Feb 20;30(9):1984–1991. doi: 10.1158/1078-0432.CCR-23-1977

Figure 5.

Figure 5. Time-dependent Kaplan–Meier analysis based on DR comparing extended letrozole versus placebo in the patients with HER2– disease in the overall BCI NSABP B-42 translational cohort and according to BCI (H/I) status.

Time-dependent Kaplan–Meier analysis based on DR comparing extended letrozole versus placebo in the patients with HER2– disease in the overall BCI NSABP B-42 translational cohort and according to BCI (H/I) status.